SEC Comment Letter for Q (QCLS) — Nov 8, 2019
Q/C TECHNOLOGIES, INC. (QCLS) (CIK 0001321834)
Date: Nov. 8, 2019 · CIK: 0001321834 · Accession: 0000000000-19-015362
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234449
Letter
November 8, 2019 Christopher Schreiber Executive Chairman Akers Biosciences, Inc. 201 Grove Road Thorofare, NJ 08086 Re:Akers Biosciences, Inc. Registration Statement on Form S-3 Filed on November 1, 2019 File No. 333-234449 Dear Mr. Schreiber: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Paul Fischer at 202-551-3415 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Sarah Williams
Show Raw Text
November 8, 2019
Christopher Schreiber
Executive Chairman
Akers Biosciences, Inc.
201 Grove Road
Thorofare, NJ 08086
Re:Akers Biosciences, Inc.
Registration Statement on Form S-3
Filed on November 1, 2019
File No. 333-234449
Dear Mr. Schreiber:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Paul Fischer at 202-551-3415 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Sarah Williams